DK0683762T3 - Acylfulven-analoger som antitumormidler - Google Patents
Acylfulven-analoger som antitumormidlerInfo
- Publication number
- DK0683762T3 DK0683762T3 DK94908702T DK94908702T DK0683762T3 DK 0683762 T3 DK0683762 T3 DK 0683762T3 DK 94908702 T DK94908702 T DK 94908702T DK 94908702 T DK94908702 T DK 94908702T DK 0683762 T3 DK0683762 T3 DK 0683762T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell
- compound
- image
- acylfulven
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
- C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
- C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/93—Spiro compounds
- C07C2603/94—Spiro compounds containing "free" spiro atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/015,179 US5439936A (en) | 1989-10-03 | 1993-02-09 | Method of treating certain tumors using illudin analogs |
| PCT/US1994/001232 WO1994018151A1 (en) | 1993-02-09 | 1994-02-02 | Acylfulvene analogues as antitumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0683762T3 true DK0683762T3 (da) | 1999-08-23 |
Family
ID=21769946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94908702T DK0683762T3 (da) | 1993-02-09 | 1994-02-02 | Acylfulven-analoger som antitumormidler |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US5439936A (da) |
| EP (1) | EP0683762B1 (da) |
| JP (1) | JP3908270B2 (da) |
| KR (1) | KR100311327B1 (da) |
| CN (1) | CN1046934C (da) |
| AT (1) | ATE174894T1 (da) |
| AU (1) | AU676889B2 (da) |
| BR (1) | BR9405689A (da) |
| CA (1) | CA2155329C (da) |
| CZ (1) | CZ288596B6 (da) |
| DE (1) | DE69415507T2 (da) |
| DK (1) | DK0683762T3 (da) |
| ES (1) | ES2125441T3 (da) |
| GR (1) | GR3029736T3 (da) |
| HU (1) | HU220059B (da) |
| MD (1) | MD1418G2 (da) |
| NO (1) | NO318648B1 (da) |
| NZ (1) | NZ262282A (da) |
| PL (1) | PL175024B1 (da) |
| RU (1) | RU2145849C1 (da) |
| TJ (1) | TJ266B (da) |
| WO (1) | WO1994018151A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932553A (en) * | 1996-07-18 | 1999-08-03 | The Regents Of The University Of California | Illudin analogs useful as antitumor agents |
| US5723632A (en) | 1996-08-08 | 1998-03-03 | Mgi Pharma, Inc. | Total synthesis of antitumor acylfulvenes |
| US7141603B2 (en) * | 1999-02-19 | 2006-11-28 | The Regents Of The University California | Antitumor agents |
| US6025328A (en) * | 1998-02-20 | 2000-02-15 | The Regents Of The University Of California | Antitumor agents |
| US7015247B2 (en) * | 2000-10-12 | 2006-03-21 | Alvin Guttag | Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs |
| US6436916B1 (en) | 2000-10-12 | 2002-08-20 | Alvin Guttag | Ibuprofen-aspirin and hydroxymethylacylfulvene analogs |
| CA2571421A1 (en) | 2004-06-24 | 2006-01-05 | Nicholas Valiante | Compounds for immunopotentiation |
| EP1909783B1 (en) * | 2005-08-03 | 2011-10-12 | The Regents of the University of California | Illudin analogs useful as anticancer agents |
| EP2389171B1 (en) * | 2009-01-26 | 2016-03-30 | Taipei Medical University | Use of pterosin compounds for treating diabetes and obesity |
| US10285955B2 (en) | 2014-04-10 | 2019-05-14 | Af Chemicals, Llc | Affinity medicant conjugate |
| CA3194672A1 (en) | 2014-04-10 | 2015-10-15 | Af Chemicals, Llc | Affinity medicant conjugates |
| US11135182B2 (en) | 2014-04-10 | 2021-10-05 | Af Chemicals, Llc | Affinity medicant conjugates |
| CN106083953A (zh) * | 2016-06-15 | 2016-11-09 | 成都医学院 | 一种从蕨菜中提取原蕨苷以及制备高纯度原蕨苷的方法 |
| WO2018170230A1 (en) * | 2017-03-15 | 2018-09-20 | Memorial Sloan Kettering Cancer Center | Diagnosis & treatment of ercc3-mutant cancer |
| WO2020051222A1 (en) * | 2018-09-04 | 2020-03-12 | Lantern Pharma Inc. | Illudin analogs, uses thereof, and methods for synthesizing the same |
| EP3667323A1 (en) | 2018-12-11 | 2020-06-17 | Kelner, Michael | Methods, compositions and devices for treating cancer with illudofulvenes |
| RU2738848C1 (ru) * | 2019-10-24 | 2020-12-17 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида |
| EP4035684A1 (en) | 2019-11-25 | 2022-08-03 | AF Chemical LLC | Affinity illudofulvene conjugates |
| US11591295B2 (en) | 2019-11-25 | 2023-02-28 | Af Chemicals Llc | Affinity illudofulvene conjugates |
| CN112972443A (zh) * | 2021-03-29 | 2021-06-18 | 杭州添帆生物科技有限公司 | 一种抗癌药物及其应用 |
| WO2023239821A2 (en) * | 2022-06-07 | 2023-12-14 | Lantern Pharma Inc. | Treating cancers with combinations of acylfulvenes with ibrutinib or bortezomib |
| WO2024016014A2 (en) * | 2022-07-15 | 2024-01-18 | Lantern Pharma Inc. | Method for treating breast cancers and parp resistant breast cancers |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2530543C (en) * | 1989-10-03 | 2008-04-01 | The Regents Of The University Of California | Illudin analogs as anti-tumor agents |
| GB9017024D0 (en) * | 1990-08-03 | 1990-09-19 | Erba Carlo Spa | New linker for bioactive agents |
| FI85318C (fi) * | 1990-08-14 | 1992-03-25 | Tecnomen Oy | Kompensering av felet i en klockas gaong. |
| JPH06223404A (ja) * | 1993-01-25 | 1994-08-12 | Mitsubishi Kasei Corp | 光学的情報記録用媒体 |
-
1993
- 1993-02-09 US US08/015,179 patent/US5439936A/en not_active Expired - Lifetime
-
1994
- 1994-02-02 PL PL94310159A patent/PL175024B1/pl not_active IP Right Cessation
- 1994-02-02 EP EP94908702A patent/EP0683762B1/en not_active Expired - Lifetime
- 1994-02-02 AU AU61700/94A patent/AU676889B2/en not_active Ceased
- 1994-02-02 NZ NZ262282A patent/NZ262282A/en not_active IP Right Cessation
- 1994-02-02 DE DE69415507T patent/DE69415507T2/de not_active Expired - Lifetime
- 1994-02-02 AT AT94908702T patent/ATE174894T1/de not_active IP Right Cessation
- 1994-02-02 ES ES94908702T patent/ES2125441T3/es not_active Expired - Lifetime
- 1994-02-02 DK DK94908702T patent/DK0683762T3/da active
- 1994-02-02 WO PCT/US1994/001232 patent/WO1994018151A1/en active IP Right Grant
- 1994-02-02 KR KR1019950703280A patent/KR100311327B1/ko not_active IP Right Cessation
- 1994-02-02 HU HU9502358A patent/HU220059B/hu not_active IP Right Cessation
- 1994-02-02 RU RU95121694A patent/RU2145849C1/ru not_active IP Right Cessation
- 1994-02-02 CN CN94191560A patent/CN1046934C/zh not_active Expired - Fee Related
- 1994-02-02 CA CA002155329A patent/CA2155329C/en not_active Expired - Fee Related
- 1994-02-02 TJ TJ96000336A patent/TJ266B/xx unknown
- 1994-02-02 CZ CZ19951986A patent/CZ288596B6/cs not_active IP Right Cessation
- 1994-02-02 BR BR9405689A patent/BR9405689A/pt not_active Application Discontinuation
- 1994-02-02 JP JP51820894A patent/JP3908270B2/ja not_active Expired - Fee Related
- 1994-02-02 MD MD96-0212A patent/MD1418G2/ro not_active IP Right Cessation
- 1994-07-15 US US08/276,169 patent/US5563176A/en not_active Expired - Lifetime
- 1994-11-01 US US08/332,940 patent/US5523490A/en not_active Expired - Lifetime
-
1995
- 1995-08-07 NO NO19953099A patent/NO318648B1/no not_active IP Right Cessation
-
1999
- 1999-03-19 GR GR990400821T patent/GR3029736T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0683762T3 (da) | Acylfulven-analoger som antitumormidler | |
| AU539976B2 (en) | Therapeutically active compounds | |
| GR3031823T3 (en) | Water soluble camptothecin analogues, processes and methods. | |
| MY102565A (en) | Novel derivatives of guanine | |
| RU2000128058A (ru) | Эктеинасцидины, фармацевтическая композиция, содержащая их и способ лечения опухолей | |
| EP1484058A3 (en) | Pharmaceutical composition for inhibiting altering gene expression and for inducing differentiation in non-malignant cells | |
| RU95121694A (ru) | Применение аналогов ацилфульвена и фармацевтическая композиция на их основе | |
| GB1260848A (en) | Propanolamine derivatives | |
| CA2179015A1 (en) | Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase | |
| MY121623A (en) | Methods of preventing breast cancer. | |
| WO1994002145A3 (en) | 2-aryl-4-quinolones as antitumor compounds | |
| FI934680A0 (fi) | Arylmorfolin, framstaellning och anvaending | |
| EP0973518A4 (en) | SEMI-SYNTHETIC PROCESSES FOR THE PREPARATION OF DIDEMNINE ANALOGS | |
| GB1500434A (en) | Tertiary amines | |
| CA2137961A1 (en) | Cyclic depsipeptides having 18 ring atoms, and their use for combating endoparasites | |
| GB1433103A (en) | Pharmacologically active pyrrolodiazepines | |
| RU94044323A (ru) | Средство ингибирования навязчиво-компульсивных состояний и расстройств потребления | |
| IE790108L (en) | Isoquinoline compounds | |
| JPS5569513A (en) | Anti-tumor agent | |
| CA1269370C (en) | SULFONO AND SULFOXO ANALOGS OF DAUNOMYCIN AND ADRIAMYCIN | |
| GB1322640A (en) | Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon | |
| JPS54151133A (en) | Antitumorigenic agent | |
| ES8303297A1 (es) | Un procedimiento para la preparacion de un nuevo reptido activo. | |
| JPS52125108A (en) | Synthesis of 1,1,1-trimethoxyethane | |
| MY103748A (en) | A new antitumor agent obtained by microbial stereoselective reduction of 4-deoxy-4-iododoxorubicin |